Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of the Anti-Histoplasma capsulatum Activity of Indole and Nitrofuran Derivatives and Their Pharmacological Safety in Three-Dimensional Cell Cultures.
Vaso CO, Bila NM, Pandolfi F, De Vita D, Bortolami M, Bonatti JLC, De Moraes Silva RA, Gonçalves LNC, Tudino V, Costi R, Di Santo R, Mendes-Giannini MJS, Costa-Orlandi CB, Scipione L, Fusco-Almeida AM. Vaso CO, et al. Among authors: bila nm. Pharmaceutics. 2022 May 12;14(5):1043. doi: 10.3390/pharmaceutics14051043. Pharmaceutics. 2022. PMID: 35631629 Free PMC article.
Incorporation of Nonyl 3,4-Dihydroxybenzoate Into Nanostructured Lipid Systems: Effective Alternative for Maintaining Anti-Dermatophytic and Antibiofilm Activities and Reducing Toxicity at High Concentrations.
Costa-Orlandi CB, Serafim-Pinto A, da Silva PB, Bila NM, Bonatti JLC, Scorzoni L, Singulani JL, Dos Santos CT, Nazaré AC, Chorilli M, Regasini LO, Fusco-Almeida AM, Mendes-Giannini MJS. Costa-Orlandi CB, et al. Among authors: bila nm. Front Microbiol. 2020 Jun 5;11:1154. doi: 10.3389/fmicb.2020.01154. eCollection 2020. Front Microbiol. 2020. PMID: 32582096 Free PMC article.
Membranolytic Activity Profile of Nonyl 3,4-Dihydroxybenzoate: A New Anti-Biofilm Compound for the Treatment of Dermatophytosis.
Costa-Orlandi CB, Bila NM, Bonatti JLC, Vaso CO, Santos MB, Polaquini CR, Santoni Biasioli MM, Herculano RD, Regasini LO, Fusco-Almeida AM, Mendes-Giannini MJS. Costa-Orlandi CB, et al. Among authors: bila nm. Pharmaceutics. 2023 May 4;15(5):1402. doi: 10.3390/pharmaceutics15051402. Pharmaceutics. 2023. PMID: 37242644 Free PMC article.